Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
7,91 USD | -2,94% | -9,39% | +6,75% |
Métier
Nombre d'employés: 8
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Proprietary Medicinal Products
100,0
%
| 0 | nan % | 6 | 100,0 % | - |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | nan % | 6 | 100,0 % | - |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Howard Berman
CEO | Chief Executive Officer | 50 | 01/01/20 |
Fred Grossman
PSD | President | 62 | 17/07/23 |
David Snyder
DFI | Director of Finance/CFO | 63 | 30/03/22 |
Michelle Frazier
LAW | General Counsel | - | 14/06/23 |
Arun Swaminathan
PRN | Corporate Officer/Principal | - | 27/03/23 |
John M. Centanni
LAW | General Counsel | - | 01/03/22 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Wilbur Ross
BRD | Director/Board Member | 85 | 19/12 |
Dov Goldstein
BRD | Director/Board Member | 56 | 14/04/21 |
Hideki Garren
BRD | Director/Board Member | 60 | 01/06/21 |
Dieter Weinand
BRD | Director/Board Member | 63 | 18/08/23 |
Director/Board Member | 65 | 25/05/21 | |
Ann Lee
BRD | Director/Board Member | 62 | 01/06/21 |
Howard Berman
CEO | Chief Executive Officer | 50 | 01/01/20 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 14 618 172 | 12 966 956 ( 88,70 %) | 0 | 88,70 % |
Coordonnées société
Coya Therapeutics, Inc.
5850 San Felipe Street Suite 500
77057, Houston
+
http://www.coyatherapeutics.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+6,75% | 120 M | |
+67,53% | 63,85 Md | |
-0,77% | 41,83 Md | |
+45,66% | 40,65 Md | |
-10,72% | 27,12 Md | |
+13,30% | 26,52 Md | |
-22,79% | 18,69 Md | |
+4,70% | 12,73 Md | |
+24,10% | 12,11 Md | |
+27,41% | 12,07 Md |
- Bourse
- Actions
- Action COYA
- Société Coya Therapeutics, Inc.